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Hydroquinone is a major benzene metabolite, which is a well-known haematotoxic and carcinogenic agent associated
with malignancy in occupational environments. Human exposure to hydroquinone can occur by dietary, occupational, and
environmental sources. In the environment, hydroquinone showed increased toxicity for aquatic organisms, being less harmful for
bacteria and fungi. Recent pieces of evidence showed that hydroquinone is able to enhance carcinogenic risk by generating DNA
damage and also to compromise the general immune responseswhichmay contribute to the impaired triggering of the host immune
reaction. Hydroquinone bioremediation from natural and contaminated sources can be achieved by the use of a diverse group of
microorganisms, ranging from bacteria to fungi, which harbor very complex enzymatic systems able to metabolize hydroquinone
either under aerobic or anaerobic conditions. Due to the recent research development on hydroquinone, this review underscores
not only the mechanisms of hydroquinone biotransformation and the role of microorganisms and their enzymes in this process,
but also its toxicity.
1. Introduction
Industrial development has caused a huge increase in the
release of potentially toxic compounds into the atmosphere,
water bodies, and soils. In the last decades, environmental
pollutants have been directly connected to the increase in
human diseases, particularly those involvedwith the immune
system. The contribution of benzene and its metabolites to
this issue is well recognized, making them a public health
problem.
Hydroquinone, the major benzene metabolite, is a ubiq-
uitous chemical in the environment due to its widespread
application in human and industrial activities. It can be
used as a developing agent in photography, dye intermediate,
stabilizer in paints, varnishes oils, and motor fuels. In addi-
tion, hydroquinone has been used as an antioxidant in the
rubber and food industry. From 1950s to 2001 hydroquinone
was applied in the commercially available cosmetic skin
lightening formulations in European Union countries and
since 1960s it was commercially available as a medical prod-
uct. It is also present in cosmetic formulations of products
for coating finger nails and hair dyes [1]. On the other
hand, hydroquinone can be a component of high molecular
aromatic compounds (e.g., resin), an intermediate, or appear
as a degradation product generated by transformation of
aromatic compounds. Advanced oxidation processes (APOs)
of aromatic compounds, particularly of phenol, yield several
benzene derivatives, such as hydroquinone, catechol, and
resorcinol, as intermediate metabolites of its transformation.
The formation of hydroquinone and 𝜌-benzoquinone at early
stages of phenol oxidation increases the toxicity of phenol
wastewaters, showing that these compounds were more toxic
and less degradable than the original pollutant [2]. Mean-
while, in the oxidative degradation of hydroquinone under a
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supercritical condition (409.9∘C and 24.5MPa) and subcrit-
ical condition (359.9∘C and 24.5MPa), 𝜌-benzoquinone was
to be an important intermediate [3]. Despite the toxic proper-
ties, a number of microorganisms can utilize hydroquinone,
especially under aerobic conditions, which has led to the
development of low-cost treatment of polluted effluents. The
chemical method applied conventionally to the treatment







the application of this technology generates ferric sulfate,
which enables recycled reactants [4]. Therefore, biological
transformations are generally preferred for being considered
as more economical and environmentally friendly.
Fungi as well as bacteria are known to be capable of trans-
forming or mineralizing hydroquinone; Aspergillus fumi-
gatus, Candida parapsilosis, Tyromyces palustris, Gloeophyl-
lum trabeum, Penicillium chrysogenum, and Phanerochaete
chrysosporium are examples of fungi able to degrade hydro-
quinone [5–9]. While several bacteria such as Pseudomonas
sp., Alcaligenes sp., and Moraxella sp. are capable of utilizing
this aromatic compound [10–15], there are a considerable
number of studies about the toxic effects of hydroquinone.
However, many of these studies have been conducted very
recently, showing the in vivo hydroquinone toxicity exposure
effects [16–20]. Hence, the aims of the present review are
firstly to outline the toxic effects of hydroquinone and
secondly to present an overview of the role of microorganism
in the degradation of hydroquinone.
2. Properties
Hydroquinone is an aromatic compound consisting of the
benzene ring and two –OH groups at para position. It is
available in the form of white crystals, but industrial use
grades may be light grey or light tan. Contact with air and
light causes oxidation and darkening of color. Hydroquinone
is soluble in water, methanol, and ether. However, it has
less solubility in water than the other two dihydroxyben-
zenes, which means hydroquinone has less affinity towards
hydrophilic solvents. Its octanol/water partition value is also
less than that of catechol and resorcinol (Table 1).
Hydroquinone can occur naturally in many plant foods,
as glucose conjugate, namely, arbutin, for example, in the
wheat, pears, coffee, onion, tea and red wine [21]. Arbutin
is readily hydrolyzed in the stomach to free hydroquinone,
which is widely absorbed by the gastrointestinal tract [22].
Hydroquinone is autoxidized by two successive one-
electron oxidations, producing an extremely reactive sem-
iquinone intermediate, which is the most reactive and
most toxic intermediate of the quinone species. Dihydrox-
ybenzene and quinones are recognized to induce oxidative
stress as well as to nonspecifically bind both DNA and
protein [23]. Hydroquinone can form complexes with various
di- and trivalente metal ions, such as copper and iron. In




production by hydroquinone and enhances its autooxidation
to benzoquinone [24].
Hydroquinone can be originated during phenol [30]
or benzene biotransformation [31]. The benzene is first
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Dipole moment 0.0D [28]
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parameter 0.21 ± 0.02 cm
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metabolized by liver cytochrome P-450 monooxygenase to
phenol. Further hydroxylation of phenol by cytochrome P-
450 monooxygenase or by human peroxidase resulted in the
formation ofmainly hydroquinone, which accumulates in the
bone marrow [32].
Hydroquinone can also be produced through three chem-
ical processes, involving oxidation, reduction, and alkylation
reactions. Firstly, it can be generated by oxidation of phenol;
secondly, the oxidation of aniline with manganese dioxide
in acidic conditions, followed by reduction with iron dust
in aqueous medium; finally, the alkylation of benzene with
propylene to originate the para-di-isopropylbenzene isomer,
besides other isomers, which is oxidized and produces the
corresponding dihydroperoxide, that is subsequently treated
with an acid to originate hydroquinone [28].
3. Toxicity
3.1. Toxicity to Aquatic and Soil Organisms. It is known
that phenolic compounds are extremely toxic for aquatic
organisms at the concentration level of part-per-million
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and most of them can influence the organolectic properties
of shellfish and fish at part-per-billion level [33]. In fact,
hydroquinone is highly toxic to aquatic organisms, such
as Pimephales promelas, Brachydanio rerio, Daphnia magna,
Desmodesmus armatus, Synechocystis sp., Nostoc sp., and
Microcystis aeruginosa [26, 34]. The acute 48 h EC
50
value
of 0.15mg/L for the marine Daphnia magna, and 24 h LC
50
values ranging from 0.22 to 0.28mg/L for Brachionus pli-
catilis have been reported [33]. Studies on Photobacterium
phosphoreum showed that hydroquinone is one hundred and
one thousand times more toxic than catechol and resorcinol,
respectively [35]. Meanwhile, it was reported that hydro-
quinone was the less toxic dihydroxybenzene to the gram-
positive bacteria Bacillus subtilis; however, it was shown that
hydroquinone and catechol mixture exerts a synergistic joint
action while the other mixtures have an additive actions [36].
The toxic effect of phenolic compounds on soil microbial
activity has been evaluated, showing hydroquinone as the
most toxic dihydroxybenzene [37]. The number of cultivable
microorganisms decreased with increasing concentration of
phenolic compounds. Furthermore, it was suggested that the
low dehydrogenase and 𝛽-glucosidase activity found in the
soils treated by hydroquinone and catechol was due to their
low water soluble carbon concentration and high inhibitory
effects, respectively [37].
Hydroquinone generally gives a negative response in the
standard bacterial gene mutations studies, such as Ames’
test [38]. Ames’ test showed that hydroquinone was not
mutagenic for Salmonella typhimurium strain TA 98, TA
100, TA 1535, and TA 1537 [39], while in yeast cells it
was reported that the exposure to 1,4-dihydroxybenzene
increases homologous recombination [40]. It has also been
suggested that hydroquinone induces aneuploidy in Saccha-
romyces cerevisiae. Shiga et al. [38] reported in Saccharomyces
cerevisiae that the hydroquinone induced G2/M transition
checkpoint, which is activated by the Hog1-Swe1 pathway,
having a role in the formation of aneuploidy. Functional
studies in vitro in yeast cells lacking the DNA helicase Sgs
1p, required for the maintenance of genomic stability, shown
reduced cellular growth in the presence of hydroquinone,
and RNAi knockdown ofWRN, the human ortholog of SGS1,
increases hydroquinone generatedDNAdamage, particularly
at high doses of dihydroxybenzene [41]. Later, North et al.
[23] postulated that Pst2p and Ycp4p, putative mitochon-
drial NAD(P)H:quinone oxidoreductases, to be novel yeast
orthologs of NQO1 (NAD(P)H:quinone oxidoreductase 1 of
humans) that are required for hydroquinone tolerance.
3.2. Toxicity to Mammalian and Human Cells. It has been
postulated that the toxicity of hydroquinone could have been
underestimated taking into account the positive data from
a limited number of confirmations in experimental animals
and the inconclusive evidence in humans [27]. Indeed, it
has been reported that hydroquinone induces mononuclear
cell leukemia, renal tubular cell tumors, and liver cancer
in rodents [42]. Tsutsui and colleagues provided pieces
of evidence that hydroquinone has cell transforming and
genotoxic activity over mammalian cells in culture. After cell
treatment with hydroquinone, the frequencies of DNA gaps,
breaks, and sister chromatid exchanges were increased as well
as chromosome aberrations [31]. Moreover, a combination
of the hydroquinone, catechol, and phenol is shown to
act synergistically, triggering oxidative DNA damage and
genotoxicity in mammalian cells in vivo [43].
Hydroquinone has been shown to be a potential toxic
agent that influences immune cell responses. It increa-
ses allergic immune responses through the increase in
interleukin(IL)-4 production and immunoglobulin E (IgE)
levels [44]. Recently, it has been reported that low levels of
in vivo hydroquinone in mice, which is not responsible for
myelotoxicity, activate oxidative stress and membrane recep-
tors in circulating neutrophils, contributing to the impaired
innate host protection against bacteria [16]. Later, it has
been shown that hydroquinone affects the lipopolysaccharide
induced cytokine secretion and nitric oxide production
by neutrophils by interfering with pretranscriptional and
posttranscriptional mechanisms [18]. Shimada et al. [20]
proposed the mechanism of in vivo hydroquinone toxicity
by exposing mice at low levels of dihydroxybenzene by
inhalation. Their findings showed that in vivo hydroquinone
exposure impairs circulating mononuclear cell migration
into the inflamed area. It was also suggested that the direct
inhibitory action of hydroquinone on monocyte chemoat-
tractant protein-1 (MCP-1) production by lung cells is directly
related to the impaired mononuclear cell chemotaxis [20].
In cultured human cells, induction of DNA strand breaks
was dependent on the presence of copper(II) ions [45]. It
was proposed that hydroquinone leads to DNA damage
through peroxide production in cells, prior internucleo-
somal DNA fragmentation leading to apoptosis [45]. Luo
and coworkers reported in human hepatoma HepG2 cells
that hydroquinone caused DNA strand breaks as well as
DNA-protein crosslinks and chromosome breaks. Further,
they postulated that hydroquinone exerts genotoxic effects
in HepG2 cells through DNA damage by oxidative stress,
being glutathione the responsible for cellular defense against
dihydroxybenzene effects [46]. There are several consistent
results on the effect of hydroquinone in the induction of sister
chromatid exchange in human lymphocytes in vitro [47–
49]. Meanwhile, hydroquinone seems to modulate immune
responses, since it inhibits lymphocyte proliferation by sup-
pression of DNA synthesis [50] and exerts a cytotoxic effect
in neutrophils, eosinophils, and lymphocytes via caspase 9/3
pathway [17, 19].
4. Biodegradation and Biotransformation
Fungi and bacteria can both degrade and transform phenolic
compounds. Filamentous fungi have the advantage to be able
to translocate resources, such as nutrients and water, between
different parts of their mycelium, which could be essential for
the transformation or detoxification of phenolic compound.
Microorganisms are, therefore, looked upon as an effective
method of removing these pollutants. Hydroquinone can
be either the reagent or the product of a transformation
process. First we will describe processes where hydroquinone
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is produced from other phenolic compounds. Next, we will
review the enzymes and pathways involved in hydroquinone
catabolism.
Degradation of hydroquinone by fungi has been reported.
The benzaldehyde and benzoic acid metabolism by the
brown-rot basidiomycetes Tyromyces palustris and Gloeo-
phyllum trabeum led to the formation of hydroquinone,
which it is further metabolized. Kamada and coworkers
reported that hydroquinone was metabolized, but no for-
mation of products was observed. Indeed, the same authors
described the effective mineralization of aromatic compound
by the brown-rot fungi using radioactive substrates [7].
The hydroxylated intermediate was also found as product
of phenol metabolism of fungi. The ascomycetous fungi,
Penicillium chrysogenum var. halophenolicum (previously
known as Penicillium chrysogenum CLONA2) is able to
complete mineralization of phenol in single and combined
phenol and glucose cultures. However, during the con-
version of phenol in the combined phenol and glucose
cultures, hydroquinone was accumulated in the early stages
of incubation and disappeared after 80 hours of culture,
indicating that hydroquinone was a metabolic intermedi-
ate, but it is not a dead-end product [8]. It has been
also detected in the biodegradation of 4-ethylphenol by
Aspergillus fumigates, another ascomycetous fungi. Accord-
ing to these authors, hydroquinone was obtained by hydrol-
ysis of 4-hydroxyphenylacetate, which undergoes further
hydroxylation to form 1,2,4-trihydroxybenzene followed by
ring fission substrate to produce maleylacetate [5].
Several aerobic bacteria are capable of utilizing hydro-
quinone as a product compound obtained from other sub-
strate, involving a hydroquinone 1,2-dioxygenase to convert
hydroquinone into 4-hydroxymuconic semialdehyde. Degra-
dation of 4-chlorophenol via hydroquinone pathway has been
reported for several strains belonging to the actinobacterium
group. Arthrobacter ureafaciens CPR706 first eliminates the
chloro-substituent to formhydroquinone.TheCPR706 strain
also degrades other para-substituted phenols, including 4-
fluoro, 4-bromo, 4-iodo, and 4-nitrophenol via the hydro-
quinone pathway [51]. According to Zhang and coworkers,
the hydroquinone pathway is also used in para-nitrophenol
degradation by gram-negative bacteria such asMoraxella sp.
[10], Pseudomonas sp. strain WBC-3 [13], and Pseudomonas
sp. 1–7 [15]. It has been reported that Pseudomonas fluorescens
ACB is able to use 4-hydroxyacetophenone through the initial
formation of 4-hydroxyphenyl acetate and hydroquinone [11,
12, 52, 53]. Meanwhile, a second pathway branch was estab-
lished for 4-chlorophenol transformation into hydroquinone,
which in turn was hydroxylated to originate hydroxyquinol
[54].
5. Key Enzymatic Players in Hydroquinone
Biodegradation and Metabolism
Hydroquinone can be degraded by two different pathways
depending on the oxygen availability. However, the anaerobic
metabolization of hydroquinone is a less frequent process in
nature, mainly restricted to a specific group of bacteria. It
involves the conversion of hydroquinone to benzoate with an
intermediate carboxylation, and activation of the products by
their linkage to acetyl-CoA (Figure 1). Cells can either employ
benzoate as an anabolic fundamental brick or introduce the
CoA-activated metabolites in the beta-oxidative catabolic
pathway.
In aerobic conditions hydroquinone is channeled to the
beta-ketoadipate pathway through two different metabolic
branches (Figure 2). The first pathway involves the initial
hydroxylation of hydroquinone to 1,2,4-trihydroxybenzene
followed by a ring-fission reaction catalyzed by a 1,2-
dioxygenase [55–57]. The second pathway of hydroquinone
degradation is less common in nature. In this pathway, hydro-
quinone ring is directly cleaved by a specific hydroquinone
1,2-dioxygenase and the generated semialdehyde oxidized
to maleylacetate [10, 58]. The first aerobic branch has been
characterized in bacteria and fungi; meanwhile, the second is
exclusive of prokaryotic organisms.
6. Degradation of Hydroquinone under
Aerobic Conditions
6.1. Catalysis of Direct Aromatic Ring Fission: 1,2-Hydrouinone
Dioxygenase. Hydroquinone 1,2-dioxygenases (HQDIOX)
are mainly bacterial enzymes able to catalyze the direct
phenolic ring fission using 1,4-dihydroxyphenols as sub-
strates and constituting a wide new family of aromatic ring-
fission enzymes. Their catalytic capabilities made them an
excellent tool for phenol bioremediation. HQDIOX can be
classified within two subfamilies of enzymes: monomeric
nonheme iron containing enzymes [59], and two-component
dioxygenases, that were originally characterized as members
of the gene clusters involved in the degradation of phenolic
pollutants in Pseudomonas [11, 12].
Monomeric hydroquinone 1,2-dioxygenases were first
characterized as a core catalytic members of the enzymatic
system responsible for the degradation of some pollutants as
pentachlorophenol (PCP).
These single chain enzymes were first described in
Mycobacterium chlorophenolicum, Sphingobium chloropheno-
licum, and Novosphingobium [59–62]. In S. chlorophenolicum
the HQDIOX is encoded by the pcpA gene, which encodes
a 37 kDa protein. PcpA protein contains a nonheme Fe atom
andhas no homologywith classical ring-fission enzymes such
as catechol dioxygenase. The enzyme is able to catalyze the
ring-opening of a wide range of substituted hydroquinones
[60, 63, 64]. In spite of the detailed knowledge of the PcpA
enzyme from S. chlorophenolicum, other putative members
of the family are present in several gram-negative bacteria
(Figure 3).
The catalytic heart of the PcpA enzyme is composed of
a non-heme iron atom coordinated by two histidines and an
aspartate (Figure 4) as observed in the crystal structure of the
PcpA enzyme from S. chlorophenolicum that has been recently
determined [64].The iron atom is located in a surface cleft of
the protein limited by two groups of antiparallel beta-strands.
Theobserved structure of PcpA suggested a potential catalytic
mechanism, whichwill be distinct from the classical extradiol
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Figure 1: Anaerobic pathway for themetabolization of hydroquinone. I: hydroquinone carboxylase; II: hydroquinoneAcetil-CoA transferase;






















Figure 2: Two different branched pathways for the biodegradation of hydroquinone under aerobic conditions. I: hydroquinone hydroxylase;
II: 1,2,4-trihydroxybenzene 1,2-dioxygenase; III: hydroquinone dioxygenase; IV: 4-hydroxymuconic semialdehyde dehydrogenase; V: beta-
ketoadipate oxidoreductase.
dioxygenases. In these enzymes, the 1,4-hydroxyl groups of
the phenolic substrate seem essential for affinity, thus other
phenols such as catechol, nitro-catechol, phenol, bromo, and
chlorophenols did not showany apparent affinity for the PcpA
protein [64].
Another family of hydroquinone 1,2-dioxygenases, com-
pletely unrelated to PcpA, has been characterized by Sph-
ingomonas and Pseudomonas with putative homologs also
present in the genomes of Photorhabdus, Burkholderia, and
Variovorax genera. They are composed of two subunits
encoded by adjacent genes in genomic clusters involved
in the degradation of substituted aromatic compounds. In
Sphingomonas sp. these genes are designated as hdqA and
hdqB [65], and the corresponding homologs in P. fluorescens
are hapC and hapD [11, 12]. In P. fluorescens, the encoding
genes are located in a cluster composed of hapCDEFGHIAB,
responsible for the biodegradation of hydroxylacetophenone
[11, 12]. The purified enzyme from P. fluorescens is a het-





molecular weight of 115 kDa. The beta-subunit, encoded by
hapD gene, has a molecular weight of 38 kDa, contains a
coordinated nonheme iron, and is also responsible for the
substrate binding. The enzyme from P. fluorescens can act
over a wide range of hydroquinone derivatives including 2-
chloro-hydroquinone, 2-methyl-hydroquinone, 2-methoxy-
hydroquinone, and 2-ethyl-hydroquinone. The enzymatic
activity over aliphatic derivatives with longer chains located
in the ortho position of the benzene ring is almost unde-
tectable, indicating the presence of a tight substrate pocket
and steric clash interactions with the substrates of higher
molecular weights. Moreover, the enzyme is not inhibited
by monophenols, but the activity is strongly decreased with
the presence of cyanide compounds, as expected for an iron-
dependent enzyme [11, 12, 53]. Apparently, the iron atom is in
the core of the catalytic mechanism that could be essentially
similar to the one postulated in the monomeric enzymes;
however, the role of the alpha small subunit of the enzyme
remains elusive and will require further investigation.
6.2. 4-Hydroxymuconic Semialdehyde Dehydrogenase. This
enzyme, responsible for the conversion of 4-hydroxymuconic
acid into maleylacetate, has been described in Pseudomonas
and Sphingomonas genera and is encoded by genes associated
to the degradation of p-nitrophenol and hydroquinone [15,
65]. In Pseudomonas, the enzyme is encoded by the hapE
gene, which encodes a protein of 487 amino acids and a
6 BioMed Research International




























































































































































































































Cupriavidus taiwanensis LMG 19424
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Figure 3: Phylogenetic circular cladogram of hydroquinone 1,2-dioxygenase sequences in diverse bacteria. Species from the genera







Figure 4: Structural features of the hydroquinone 1,2-hydroxylase from S. chlorophenolicum, as determined by X-ray crystallography (PDB
code: 4HUZ). (a) Overall folding of the enzyme depicting the central position of the iron atom; (b) close view of the coordinating residues
and the Fe atom environment. The sulfate ion close to the iron atom comes from the crystallization media.
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calculated molecular weight of 50 kDa. Other homologs of
HapE protein are also present in Burkholderia sp., Sphin-
gomonas sp., Azospirillum amazonense, and in Brachymonas
petroleovorans. The enzyme is an oxidoreductase that used
NADP nucleotides as electron acceptors [11, 12, 66]. It
belongs to the NAD(P)-dependent aldehyde dehydrogenase
superfamily, a group of enzymeswith an important role either
in detoxification reactions or in other metabolic pathways.
6.3. Hydroquinone Hydroxylases: A Member of a Complex
Family of Enzymes. Hydroquinone hydroxylase belongs to
the family of phenol 2-monooxygenases showing wider
substrate specificity when compared with hydroquinone
dioxygenases. This enzymatic activity has been extensively
characterized in anamorphic yeasts as Trichosporon cuta-
neum [67, 68] andCandida [6, 69] as well as in several species
of gram-negative bacteria [65, 70].
Phenol oxygenases are classified into two main groups:
one family of monomeric enzymes and another one com-
posed of multicomponent proteins. Interestingly, genes
encoding monomeric hydroquinone hydroxylases are typi-
cally encoded in plasmid DNA, whereas the multicompo-
nent proteins are encoded by genes located in the bacterial
chromosome. The monomeric enzymes are environmentally
relevant due to their presence in mobile genetic systems
that can be transferred between different cells. In bacteria,
hydroquinone hydroxylase activity has been associated to
monomeric iron-containing metalloenzymes. In Acinetobac-
ter and Pseudomonas the enzyme containing an iron-sulfur
cluster of the type 2Fe-2S [71] is responsible for the electron
transfer from the substrate to the reduced cofactor NADH
[72, 73].
Moreover in Pseudomonas, another family of phenol
monooxygenases able to use hydroquinone as a substrate
and belonging to the multicomponent group has been
also described. Bacterial multicomponent monooxygenases
(BMMs) consist of a protein complex with 250–300 kDa
complex containing a dimeric hydroxylase (PHH) of the form
(𝛼𝛽𝛾)
2
, a small regulatory protein (PHM) and a flavoprotein
containing an iron-sulphur cluster (PHP), which acts as
reductase supplying electrons to the hydroxylase component
and consuming NADH as a cofactor. In spite of their
structural complexity (Figure 5), multicomponent phenol
monooxygenases are extremely efficient enzymes, able to act
over a wide range of substrates as nitro, amino, and methyl-
phenols and also halogenated phenols [74, 75]. They are
typically inhibited by their substrates and also by inorganic
anions such as nitrite, sulfate, and phosphate, showing a
slightly alkaline optimum pH. The complexity of the mul-
ticomponent phenol monooxygenase is still far from being
understood, since many additional protein components have
been recently discovered. In fact genes encoding BMMs are
located in a genomic cluster. Accessory components such as
PHK protein have been described as enhancers of the overall
catalytic activity of the complex [70].
In eukaryotes, phenol hydroxylases with activity over
hydroquinone are enzymes encoded by chromosomic genes,
with a molecular weight of about 150 kDa, and acting as
functional dimers. Hydroquinone hydroxylase fromCandida
parapsilosis and phenol hydroxylase from Trichosporon cuta-
neum are ClassA flavoprotein monooxygenases [76]. In yeast
hydroquinone hydroxylase activity is induced when the cells
are grown on mono- or dihydroxy benzoic acids as a sole
source of carbon and energy [6].
Hydroquinone hydroxylase contains a tightly noncova-
lently bound FAD cofactor per each monomer, which is
essential for the physiological reconstitution of the apoen-
zyme (Figure 6) [6]. Structural studies, performed by X-ray
crystallography in the T. cutaneum hydroquinone hydroxy-
lase, showed that the protein is composed of three clearly
defined domains (Figure 6). The first domain is composed
of a beta-sheet which forms the FAD binding site and also
the substrate pocket close to the interface with the second
domain. In the third domain a thioredoxin-like fold is
responsible for the protein-protein interactions that built up
the apoenzyme dimer [77]. Eukaryotic phenol hydroxylases
are able to act over simple phenols, over amino, halogen as
well as methyl-phenol derivatives with the only requirement
of having a free ortho position in the phenolic ring.
6.4. 1,2,4-Trihydroxybenzene 1,2-Dioxygenase. Also known as
hydroxyquinol 1,2-dioxygenase (1,2-HQD), 1,2-HDQs belong
to the intradiol dioxygenase family and catalyze the oxidative
ring cleavage of substituted 1,2-dihydroxy-benzenes. In bac-
teria and fungi, these enzymes are homodimers composed
of two identical subunits of 30–35 kDa, tightly packed that
suggests a possible allosteric interaction between catalytic
monomers. They have been described in gram-negative
bacteria (Burkholderia cepacia,Azotobacter sp., andRalstonia
pickettii), gram-positive bacteria (Nocardioides simplex and
Arthrobacter sp.), and fungi (T. cutaneum and Phanerochaete
chrysosporium) [51, 78–85].
1,2-HQDs are iron-dependent dioxygenases, containing a
nonheme pentacoordinated Fe(III) atom located close to the
substrate binding pocket. This catalytic cavity for substrate
binding is composed of a tridimensional arrangement of
beta-sheets together with a number of random coils that open
a small hydrophobic concavity that will position the substrate
close to the iron atom.The proposed catalytic mechanism for
intradiol 1,2 cleavage has been recently proposed based on the
crystallographic structure of 1,2-HQD from N. simplex [84].
The enzyme is able to catalyze the aromatic ring fission by
a mechanism that involves the formation of an intermediate
oxo-adduct and a seven-membered ring (Figure 7).
As reported in the tridimensional structure of the 1,2-
HQD, the substrate specificity of the enzyme is expected to
be controlled by the aromatic ring substituents (Figure 8).
In fact 1,2-HQD is more similar to the Type I of intradiol
dioxygenases, which showed an increased specificity in their
substrates [84, 86].
Studies performed with diverse 1,2-HQD enzymes
showed a decreased affinity and catalytic activity over
catechol, pyrogallol, and other substituted dihydroxyben-
zenes in comparison with 1,2,4-trihydroxybenzene. Intere-
stingly, the sequence comparison of 1,2-HQDs among
diverse microorganisms showed a divergent evolution
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Figure 5: Ribbons representation of the overall tridimensional structure of the catalytic core PHH of the phenol monooxygenase from
Pseudomonas sp. in complex with the regulatory subunit PHM (PDB code: 2INN). The catalytic core of the enzyme is composed of a dimer
of three subunits 𝛼𝛽𝛾 [73, 74].
pattern between these families of enzymes and other
catechol dioxygenases, indicating that the development of
substrate specificity for hydroquinone was a very important
step in the evolution of pathways for the efficient degradation
of natural and xenobiotic compounds with a benzene nucleus
[83, 87, 88].
7. Hydroquinone Degradation under
Anaerobic Environment
The presence of two hydroxyl groups in para orientation
within the benzene ring makes improbable that any microor-
ganism would be able to catalyze direct oxidative ring fission
of hydroquinone under anaerobic conditions. On the con-
trary, anaerobic hydroquinone-degrading microorganisms
will engage a diverted pathway which involves a carboxyla-
tion and activation with CoA to finish with the production
of benzoate and the introduction of this compound into
the classical anaerobic benzene metabolization pathways [89,
90]. In spite of their bioremediation potential, there are just
a few reported examples in the literature describing anaero-
bic organisms able to degrade hydroquinone. They include
sulfate-reducing bacteria from the genus Desulfococcus [91,
92] and dehalogenating bacteria isolated from soil consortia
together with filamentous fungi [93, 94].
The hydroquinone anaerobic biodegradation pathway
starts with a carboxylation to produce gentisate (2,5-
dihydroxybenzoate), catalyzed by an uncharacterized car-
boxylase enzyme that is inducible by the presence of hydro-
quinone as a sole source of carbon and energy in anaerobic
conditions [91, 92]. After the synthesis of gentisate, this
compound will be activated by the addition of a CoA
group. This is a classical reaction step in the utilization of
phenolic compounds by anaerobic microorganisms [95].The
corresponding CoA-ligase involved uses only Acyl-CoA as a
donor, with no evidence of catalytic activity using acetyl or
phenyl-CoA donors [91, 92]. The most interesting reaction
of the whole pathway is the reductive dehydroxylation of
the gentisyl-CoA. This reaction is catalyzed by an oxygen-
sensitive enzyme, which removes both hydroxyl groups in
one single step, and probably associated to cell membranes
[90–92]. However, further investigations are required to
characterize this enzymatic activity. The gentisyl-CoA dehy-
droxylase will generate benzoate as a final product that
will engage the anaerobic benzoate pathway for its final
degradation towards beta-oxidation.
8. Final Remarks
Hydroquinone is a highly redox-active compound, which can
promote the formation of reactive oxygen species, oxidative
stress, and DNA damage. Despite the fact that the molecular
modes of action of hydroquinone in disease remain unclear,
it has been proposed that it could act in a synergistic way by
inducing general DNAdamage together with a specific action
over the mitotic spindle, and inhibition of topoisomerase II
that could result inDNAstrand breaks via production of reac-
tive oxygen species (ROS). Recent studies also showed that
hydroquinone promotes tumor cell growth and suppresses
the immune response.
Many industrial pollutants, as well as natural metabolites,
are phenolic compounds, and the degradation of these
aromatic molecules is important in what concerns to carbon
cycle. The incredible versatility inherited in microorganism
either due to its tolerance for extreme conditions or by the
capability to adapt its enzymatic system to the environment
challenges, makes bioremediation an excellent method to
clean phenolic compounds in an economical and friendly
manner. Several microorganisms catalyze mineralization











Figure 6: Structure of phenol hydroxylase from T. cutaneum as determined by X-ray crystallography (PDB code: 1PN0), an enzyme also
able to act over hydroquinone. (a) Overall fold showing the structure of the three structural domains and the location of FAD cofactor and
phenolic substrate in the catalytic pocket of the enzyme between domains 1 and 2; (b) detailed view of the catalytic pocket, showing the
phenolic substrate close to the FAD cofactor; (c) close-up view of the residues involved in the formation of a narrow substrate hole that
accommodates monophenols, and located in a flexible protein region that also interacts with the FAD cofactor.The substrate-cofactor pocket
is composed of a continuous cavity in the protein body, which is closed by the flavin ring of the FAD cofactor avoiding the escape of the
substrate.
and/or transformation of hydroquinone either by aerobic
or anaerobic processes, although the last one being less
frequent. The knowledge of substrate specificity and toxicity
patterns is needed in order to select strains with the required
properties for efficient bioremediation. In fact, the inherent
chemical properties of hydroquinonemade it a poor substrate
for classical phenol oxygenases, because the orientation of
the two hydroxyl groups in para prevents further aromatic
ring oxidations. Challenging the basic laws of chemistry,
several microorganisms have developed extremely efficient
enzymes which are able even to catalyze direct hydroquinone
ring fission. Enzymatic systems designed for hydroquinone
degradation are excellent examples of an elegant molecular
design triggered by the natural selection. These enzymatic
activities are promising tools for bioremediation of hydro-
quinone and its derivatives, and guided by the Synthetic
Biology principles could be modeled, combined, and applied
for targeted bioremediation of a wide family of phenolic
compounds.
This review summarizes information on the biodegra-
dation and biotransformation pathways of hydroquinone by
different microorganisms as well as the recent development
on its toxicity to mammalian and human cells.The character-
ization andmechanisms of action of themajor hydroquinone
detoxifying enzymes are also discussed. There are many
factors, both biotic and abiotic, that influence the degradation
of hydroquinone. Understanding and manipulating the flux
of hydroquinone in the environment therefore require more
holistic approaches, such as systems biology. It is known
that each component involved in the biotransformation
of hydroquinone and their interactions should be studied
to provide the real scenario, which indeed constitutes a































Figure 7: Proposed reaction mechanism for hydroxyquinol intradiol 1,2-dioxygenase. The enzyme catalyzed the ring-fission reaction by









Figure 8: Tridimensional structure of the catalytic homodimer of hydroxyquinol 1,2-dioxygenase from N. simplex as determined by X-ray
crystallography (PDB code: 1TMX). (a) Global structure of the homodimer showing the tight packing between subunits; (b) close look to the
iron center, coordinating amino acids, and substrate binding site close to the iron atom.The structure of hydroxyquinol 1,2-dioxygenase was
solved in the presence of benzoate, a competitive inhibitor which binds to the substrate binding site.
BioMed Research International 11
bottleneck to the scale up in order to achieve the desired
outputs of bioremediation.
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and J. J. Rodriguez, “Evolution of toxicity upon wet catalytic
oxidation of phenol,” Environmental Science and Technology,
vol. 38, no. 1, pp. 133–138, 2004.
[3] C. Thammanayakatip, Y. Oshima, and S. Koda, “Inhibition
effect in supercritical water oxidation of hydroquinone,” Indus-
trial and Engineering Chemistry Research, vol. 37, no. 5, pp. 2061–
2063, 1998.
[4] Q. Geng, Q. Guo, C. Cao, and L. Wang, “Investigation into
NanoTiO
2
/ACSPCR for decomposition of aqueous hydro-
quinone,” Industrial and Engineering Chemistry Research, vol.
47, no. 8, pp. 2561–2568, 2008.
[5] K. H. Jones, P. W. Trudgill, and D. J. Hopper, “4-Ethylphenol
metabolism byAspergillus fumigatus,”Applied and Environmen-
tal Microbiology, vol. 60, no. 6, pp. 1978–1983, 1994.
[6] M. H. M. Eppink, E. Cammaart, D. Van Wassenaar, W. J. Mid-
delhoven, andW. J. H. Van Berkel, “Purification and properties
of hydroquinone hydroxylase, a FAD-dependent monooxyge-
nase involved in the catabolism of 4-hydroxybenzoate in Can-
dida parapsilosis CBS604,” European Journal of Biochemistry,
vol. 267, no. 23, pp. 6832–6840, 2000.
[7] F. Kamada, S. Abe, N. Hiratsuka, H. Wariishi, and H.
Tanaka, “Mineralization of aromatic compounds by brown-rot
basidiomycetes-mechanisms involved in initial attack on the
aromatic ring,” Microbiology, vol. 148, no. 6, pp. 1939–1946,
2002.
[8] A. L. Leitão, M. P. Duarte, and J. S. Oliveira, “Degradation of
phenol by a halotolerant strain of Penicillium chrysogenum,”
International Biodeterioration and Biodegradation, vol. 59, no.
3, pp. 220–225, 2007.
[9] T. Nakamura, H. Ichinose, and H. Wariishi, “Flavin-containing
monooxygenases from Phanerochaete chrysosporium responsi-
ble for fungal metabolism of phenolic compounds,” Biodegra-
dation, vol. 23, no. 3, pp. 343–350, 2012.
[10] J. C. Spain and D. T. Gibson, “Pathway for biodegradation of
p-nitrophenol in a Moraxella sp,” Applied and Environmental
Microbiology, vol. 57, no. 3, pp. 812–819, 1991.
[11] M. J. H. Moonen, N. M. Kamerbeek, A. H. Westphal et al.,
“Elucidation of the 4-hydroxyacetophenone catabolic pathway
in Pseudomonas fluorescens ACB,” Journal of Bacteriology, vol.
190, no. 15, pp. 5190–5198, 2008.
[12] M. J. H. Moonen, S. A. Synowsky, W. A. M. Van Den Berg et
al., “Hydroquinone dioxygenase from Pseudomonas fluorescens
ACB: a novel member of the family of nonheme-iron(II)-
dependent dioxygenases,” Journal of Bacteriology, vol. 190, no.
15, pp. 5199–5209, 2008.
[13] J.-J. Zhang, H. Liu, Y. Xiao, X.-E. Zhang, andN.-Y. Zhou, “Iden-
tification and characterization of catabolic para-nitrophenol 4-
monooxygenase and para-benzoquinone reductase from pseu-
domonas sp. strainWBC-3,” Journal of Bacteriology, vol. 191, no.
8, pp. 2703–2710, 2009.
[14] T. Essam, M. A. Amin, O. E. Tayeb, B. Mattiasson, and B.
Guieysse, “Kinetics and metabolic versatility of highly tolerant
phenol degradingAlcaligenes strain TW1,” Journal of Hazardous
Materials, vol. 173, no. 1–3, pp. 783–788, 2010.
[15] S. Zhang, W. Sun, L. Xu et al., “Identification of the para-
nitrophenol catabolic pathway, and characterization of three
enzymes involved in the hydroquinone pathway, in pseu-
domonas sp. 1-7,” BMCMicrobiology, vol. 12, article 27, 2012.
[16] A. L. T. Ribeiro, A. L. B. Shimada, C. B. Hebeda et al.,
“In vivo hydroquinone exposure alters circulating neutrophil
activities and impairs LPS-induced lung inflammation inmice,”
Toxicology, vol. 288, no. 1–3, pp. 1–7, 2011.
[17] E. J. Yang, J.-S. Lee, C.-Y. Yun, and I. S. Kim, “The pro-apoptotic
effect of hydroquinone in human neutrophils and eosinophils,”
Toxicology in Vitro, vol. 25, no. 1, pp. 131–137, 2011.
[18] C. B. Hebeda, F. J. Pinedo, S. M. Bolonheis et al., “Intracellular
mechanisms of hydroquinone toxicity on endotoxin-activated
neutrophils,” Archives of Toxicology, vol. 86, pp. 1773–1781, 2012.
[19] J.-S. Lee, E. J. Yang, and I. S. Kim, “Hydroquinone-induced
apoptosis of human lymphocytes through caspase 9/3 pathway,”
Molecular Biology Reports, vol. 39, pp. 6737–6743, 2012.
[20] A. L. B. Shimada, A. L. T. Ribeiro, S.M. Bolonheis, V. Ferraz-de-
Paula, C. B. Hebeda, and S. H. P. Farsky, “In vivo hydroquinone
exposure impairs MCP-1 secretion and monocyte recruitment
into the inflamed lung,” Toxicology, vol. 296, no. 1–3, pp. 20–26,
2012.
[21] P. J. Deisinger, T. S. Hill, and J. C. English, “Human exposure
to naturally occurring hydroquinone,” Journal of Toxicology and
Environmental Health, vol. 47, no. 1, pp. 31–46, 1996.
[22] T. A. McDonald, N. T. Holland, C. Skibola, P. Duramad, and
M. T. Smith, “Hypothesis: phenol and hydroquinone derived
mainly from diet and gastrointestinal flora activity are causal
factors in leukemia,” Leukemia, vol. 15, no. 1, pp. 10–20, 2001.
[23] M. North, V. J. Tandon, R. Thomas et al., “Genome-Wide
functional profiling reveals genes required for tolerance to
benzene metabolites in yeast,” PLoS ONE, vol. 6, no. 8, Article
ID e24205, 2011.
[24] C. Sarkar, P. K. Mitra, S. Saha, C. Nayak, and R. Chakraborty,
“Effect of copper-hydroquinone complex on oxidative stress-
related parameters in human erythrocytes (in vitro),”Toxicology
Mechanisms and Methods, vol. 19, no. 2, pp. 86–93, 2009.
[25] I. Rychlinska and S. Nowak, “Quantitative determination of
arbutin and hydroquinone in different plant materials by
HPLC,”Notulae Botanicae Horti Agrobotanici Cluj-Napoca , vol.
40, pp. 109–113, 2012.
[26] OECD SIDS, “Hydroquinone,” CAS 123-31-9, UNEP Publica-
tions, 2012.
[27] D. McGregor, “Hydroquinone: an evaluation of the human
risks from its carcinogenic and mutagenic properties,” Critical
Reviews in Toxicology, vol. 37, no. 10, pp. 887–914, 2007.
[28] S. Suresh, V. C. Srivastava, and I. M. Mishra, “Adsorption
of catechol, resorcinol, hydroquinone, and their derivatives:
a review,” International Journal of Energy and Environmental
Engineering, vol. 3, article 32, 2012.
[29] Y. Song, J. Xie, Y. Song et al., “Calculation of standard electrode
potential of half reaction for benzoquinone and hydroquinone,”
Spectrochimica Acta Part A, vol. 65, no. 2, pp. 333–339, 2006.
12 BioMed Research International
[30] T. Sawahata and R. A. Neal, “Biotransformation of phenol to
hydroquinone and catechol by rat liver microsomes,”Molecular
Pharmacology, vol. 23, no. 2, pp. 453–460, 1983.
[31] T. Tsutsui, N. Hayashi, H. Maizumi, J. Huff, and J. C. Bar-
rett, “Benzene-, catechol-, hydroquinone- and phenol-induced
cell transformation, gene mutations, chromosome aberrations,
aneuploidy, sister chromatid exchanges and unscheduled DNA
synthesis in Syrian hamster embryo cells,” Mutation Research,
vol. 373, no. 1, pp. 113–123, 1997.
[32] V. V. Subrahmanyam, P. Kolachana, and M. T. Smith, “Hydrox-
ylation of phenol to hydroquinone, catalyzed by a human
myeloperoxidase-superoxide complex: possible implications in
benzene-inducedmyelotoxicity,”Free Radical ResearchCommu-
nications, vol. 15, no. 5, pp. 285–296, 1991.
[33] R. Guerra, “Ecotoxicological and chemical evaluation of phe-
nolic compounds in industrial effluents,” Chemosphere, vol. 44,
no. 8, pp. 1737–1747, 2001.
[34] H. Bahrs, A. Putschew, and C. E. Steinberg, “Toxicity of hydro-
quinone to different freshwater phototrophs is influenced by
time of exposure and pH,” Environmental Science and Pollution
Research, vol. 20, pp. 146–154, 2013.
[35] K. L. E. Kaiser and V. S. Palabrica, “Photobacterium phospho-
reum toxicity data index,” Water Pollution Research Journal of
Canada, vol. 26, no. 3, pp. 361–431, 1991.
[36] H. Chen, J. Yao, F. Wang et al., “Toxicity of three phenolic
compounds and their mixtures on the gram-positive bacteria
Bacillus subtilis in the aquatic environment,” Science of the Total
Environment, vol. 408, no. 5, pp. 1043–1049, 2010.
[37] H. Chen, J. Yao, F. Wang, M. M. F. Choi, E. Bramanti, and G.
Zaray, “Study on the toxic effects of diphenol compounds on
soil microbial activity by a combination of methods,” Journal of
Hazardous Materials, vol. 167, no. 1-3, pp. 846–851, 2009.
[38] T. Shiga, H. Suzuki, A. Yamamoto, H. Yamamoto, and K.
Yamamoto, “Hydroquinone, a benzene metabolite, induces
Hog1-dependent stress response signaling and causes ane-
uploidyin Saccharomyces cerevisiae,” Journal of Radiation
Research, vol. 51, no. 4, pp. 405–415, 2010.
[39] I. Florin, L. Rutberg, M. Curvall, and C. R. Enzell, “Screening of
tobacco smoke constituents for mutagenicity using the Ames’
test,” Toxicology, vol. 15, no. 3, pp. 219–232, 1980.
[40] C. H. Sommers and R. H. Schiestl, “Effect of benzene and its
closed ringmetabolites on intrachromosomal recombination in
Saccharomyces cerevisiae,” Mutation Research, vol. 593, no. 1-2,
pp. 1–8, 2006.
[41] Q. Lan, L. Zhang, M. Shen et al., “Large-scale evaluation of
candidate genes identifies associations betweenDNA repair and
genomicmaintenance and development of benzene hematotox-
icity,” Carcinogenesis, vol. 30, no. 1, pp. 50–58, 2009.
[42] F. W. Kari, J. Bucher, S. L. Eustis, J. K. Haseman, and J. E. Huff,
“Toxicity and carcinogenicity of hydroquinone in F344/N rats
and B6C3F1 mice,” Food and Chemical Toxicology, vol. 30, no. 9,
pp. 737–747, 1992.
[43] A. Marrazzini, L. Chelotti, I. Barrai, N. Loprieno, and R. Barale,
“In vivo genotoxic interactions among three phenolic benzene
metabolites,”Mutation Research, vol. 341, no. 1, pp. 29–46, 1994.
[44] M. H. Lee, S. W. Chung, B. Y. Kang, K.-M. Kim, and T.
S. Kim, “Hydroquinone, a reactive metabolite of benzene,
enhances interleukin-4 production in CD4+ T cells and
increases immunoglobulin E levels in antigen-primed mice,”
Immunology, vol. 106, no. 4, pp. 496–502, 2002.
[45] Y. Hiraku and S. Kawanishi, “Oxidative DNA damage and
apoptosis induced by benzene metabolites,” Cancer Research,
vol. 56, no. 22, pp. 5172–5178, 1996.
[46] L. Luo, L. Jiang, C. Geng, J. Cao, and L. Zhong, “Hydroquinone-
induced genotoxicity and oxidative DNA damage in HepG2
cells,” Chemico-Biological Interactions, vol. 173, no. 1, pp. 1–8,
2008.
[47] K. Morimoto, S. Wolff, and A. Koizumi, “Induction of sister-
chromatid exchanges in human lymphocytes by microsomal
activation of benzene metabolites,”Mutation Research, vol. 119,
no. 3-4, pp. 355–360, 1983.
[48] G. L. Erexson, J. L. Wilmer, and A. D. Kligerman, “Sister
chromatid exchange induction in human lymphocytes exposed
to benzene and its metabolites in vitro,” Cancer Research, vol.
45, no. 6, pp. 2471–2477, 1985.
[49] S. Knadle, “Synergistic interaction between hydroquinone and
acetaldehyde in the induction of sister chromatid exchange in
human lymphocytes in vitro,” Cancer Research, vol. 45, no. 10,
pp. 4853–4857, 1985.
[50] Q. Li, L. Geiselhart, J. N. Mittler, S. P. Mudzinski, D. A.
Lawrence, andB.M. Freed, “Inhibition of humanT lymphoblast
proliferation by hydroquinone,” Toxicology and Applied Phar-
macology, vol. 139, no. 2, pp. 317–323, 1996.
[51] H. S. Bae, J. M. Lee, and S.-T. Lee, “Biodegradation of 4-
chlorophenol via a hydroquinone pathway by Arthrobacter
ureafaciens CPR706,” FEMS Microbiology Letters, vol. 145, no.
1, pp. 125–129, 1996.
[52] F. K. Higson and D. D. Focht, “Bacterial degradation of
ring-chlorinated acetophenones,” Applied and Environmental
Microbiology, vol. 56, no. 12, pp. 3678–3685, 1990.
[53] N. M. Kamerbeek, M. J. H. Moonen, J. G. M. Van Der
Ven, W. J. H. Van Berkel, M. W. Fraaije, and D. B. Janssen,
“4-Hydroxyacetophenone monooxygenase from Pseudomonas
fluorescensACB. A novel flavoprotein catalyzing Baeyer-Villiger
oxidation of aromatic compounds,” European Journal of Bio-
chemistry, vol. 268, no. 9, pp. 2547–2557, 2001.
[54] K. Nordin, M. Unell, and J. K. Jansson, “Novel 4-chlorophenol
degradation gene cluster and degradation route via hydrox-
yquinol in Arthrobacter chlorophenolicus A6,” Applied and
EnvironmentalMicrobiology, vol. 71, no. 11, pp. 6538–6544, 2005.
[55] J. J. Anderson and S. Dagley, “Catabolism of aromatic acids in
Trichosporon cutaneum,” Journal of Bacteriology, vol. 141, no. 2,
pp. 534–543, 1980.
[56] W. J. H. Van Berkel, M. H.M. Eppink,W. J. Middelhoven, J. Ver-
vorrt, andM.C.M.Rietjens, “Catabolismof 4-hydroxybenzoate
in Candida parapsilosis proceeds through initial oxidative
decarboxylation by a FAD-dependent 4-hydroxybenzoate 1-
hydroxylase,” FEMSMicrobiology Letters, vol. 121, no. 2, pp. 207–
216, 1994.
[57] S. Takenaka, S. Okugawa, M. Kadowaki, S. Murakami, and K.
Aoki, “The metabolic pathway of 4-aminophenol in Burkholde-
ria sp. strain AK-5 differs from that of aniline and aniline with
C-4 substituents,”Applied and Environmental Microbiology, vol.
69, no. 9, pp. 5410–5413, 2003.
[58] J. M. Darby, D. G. Taylor, and D. J. Hopper, “Hydroquinone as
the ring-fission substrate in the catabolismof 4-ethylphenol and
4-hydroxyacetophenone by Pseudomonas putida JD1,” Journal
of General Microbiology, vol. 133, pp. 2137–2146, 1987.
BioMed Research International 13
[59] L. Xun, J. Bohuslavek, and M. Cai, “Characterization of 2,6-
dichloro-p-hydroquinone 1,2-dioxygenase (PcpA) of Sphin-
gomonas chlorophenolica ATCC 39723,” Biochemical and Bio-
physical Research Communications, vol. 266, no. 2, pp. 322–325,
1999.
[60] Y. Ohtsubo, K. Miyauchi, K. Kanda et al., “PcpA, which is
involved in the degradation of pentachlorophenol in Sphin-
gomonas chlorophenolica ATCC39723, is a novel type of ring-
cleavage dioxygenase,” FEBS Letters, vol. 459, no. 3, pp. 395–398,
1999.
[61] L. Xu, K. Resing, S. L. Lawson, P. C. Babbitt, and S. D. Copley,
“Evidence that pcpA encodes 2,6-dichlorohydroquinone dioxy-
genase, the ring cleavage enzyme required for pentachlorophe-
nol degradation in Sphingomonas chlorophenolica strain ATCC
39723,” Biochemistry, vol. 38, no. 24, pp. 7659–7669, 1999.
[62] T. E. MacHonkin, P. L. Holland, K. N. Smith et al., “Determi-
nation of the active site of Sphingobium chlorophenolicum 2,6-
dichlorohydroquinone dioxygenase (PcpA),” Journal of Biologi-
cal Inorganic Chemistry, vol. 15, no. 3, pp. 291–301, 2010.
[63] W. Sun, R. Sammynaiken, L. Chen et al., “Sphingobium
chlorophenolicum dichlorohydroquinone dioxygenase (PcpA) is
alkaline resistant and thermally stable,” International Journal of
Biological Sciences, vol. 7, no. 8, pp. 1171–1179, 2011.
[64] R. P. Hayes, A. R. Green, M. S. Nissen, K. M. Lewis,
L. Xun, and C. Kang, “Structural characterization of 2,6-
dichloro-p-hydroquinone 1,2-dioxygenase (PcpA) from Sphin-
gobium chlorophenolicum, a new type of aromatic ring-cleavage
enzyme,” Molecular Microbiology, vol. 88, no. 3, pp. 523–536,
2013.
[65] B. A. Kolvenbach, M. Lenz, D. Benndorf et al., “Purification
and characterization of hydroquinone dioxygenase from Sphin-
gomonas sp. strain TTNP3,” AMB Express, vol. 1, article 8, 2011.
[66] S. Vikram, J. Pandey, N. Bhalla et al., “Branching of the p-
nitrophenol (PNP) degradation pathway in Burkholderia sp.
Strain SJ98: evidences from genetic characterization of PNP
gene cluster,” AMB Express, vol. 2, article 30, 2012.
[67] M.Kalin,H. Y.Neujahr, R.N.Weissmahr et al., “Phenol hydrox-
ylase from Trichosporon cutaneum: gene cloning, sequence
analysis, and functional expression in Escherichia coli,” Journal
of Bacteriology, vol. 174, no. 22, pp. 7112–7120, 1992.
[68] M. Gerginova, J. Manasiev, N. Shivarova, and Z. Alexieva,
“Influence of various phenolic compounds on phenol hydrox-
ylase activity of a Trichosporon cutaneum strain,” Zeitschrift fur
Naturforschung C, vol. 62, no. 1-2, pp. 83–86, 2007.
[69] L. Vilimkova, J. Paca, V. Kremlackova, and M. Stiborova, “Iso-
lation of cytoplasmic NADPH-dependent phenol hydroxylase
and catechol-1,2-dioxygenase from Candida tropicalis yeast,”
Interdiscip Toxicol, vol. 1, pp. 225–230, 2008.
[70] V. Izzo, G. Leo, R. Scognamiglio, L. Troncone, L. Birolo, and A.
Di Donato, “PHK from phenol hydroxylase of Pseudomonas sp.
OX1. Insight into the role of an accessory protein in bacterial
multicomponent monooxygenases,” Archives of Biochemistry
and Biophysics, vol. 505, no. 1, pp. 48–59, 2011.
[71] E. Cadieux,V.Vrajmasu, C.Achim, J. Powlowski, andE.Münck,
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